The Global Aerosol Drug Delivery Devices Market Size is Anticipated to Exceed USD 60,270 Million by 2033, Growing at a CAGR of 4.70% from 2023 to 2033. Aerosol drug delivery devices are medical equipment that administer medication directly to the respiratory system by inhalation. These devices are used to treat various respiratory disorders, such as asthma, chronic obstructive pulmonary disease (COPD), and other lung difficulties.